ASHFORD CAPITAL MANAGEMENT INC

Position in ADMA — Adma Biologics, Inc.

CIK 897070 WILMINGTON, DE

Position in ADMA

as of Jun 30, 2026 · filed Aug 21, 2026 Compact

Position Value

$2,822,531

-$434,584 QoQ

Shares Held

337,220

-6.7% QoQ

Ownership

0.151%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

#68

of 323 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ASHFORD CAPITAL MANAGEMENT INC holds $81,793,326 across 4 Biotechnology names. ADMA ranks #4 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	170,236	$53,809,897
2	INCY	Incyte Corp	182,177	$20,651,584
3	VRTX	Vertex Pharmaceuticals Inc / Ma	9,078	$4,509,314
4	ADMA	Adma Biologics, Inc. This page	337,220	$2,822,531

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,822,531	337,220	-6.7%	Shares	Sole	2026-08-21
2026-03-31	$3,257,115	361,500	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.